CLASS II Drug recall · Reported 26 Sep 2018 · FDA Enforcement Report

Tizanidine HCl Tablets, USP 2mg recalled by Dr. Reddy's Laboratories

Dr. Reddy's Laboratories is recalling Tizanidine HCl Tablets, USP 2mg, distributed nationwide in the US. The recall was initiated on 4 Sep 2018 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesLot #: T800304, Exp. 03/2021
NDC55111-179, 55111-180
UPC0355111180104, 0355111179108
Quantity recalled8376 units

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

Recall details

Recall number
D-1191-2018
FDA event ID
80953
Recalling firm
Dr. Reddy's Laboratories, Princeton, NJ
Manufacturer
Dr. Reddy's Laboratories Limited
Classification
Class II
Status
Terminated
Recall initiated
4 Sep 2018
FDA classified
17 Sep 2018
Reported
26 Sep 2018
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Other Reasons

Timeline

4 Sep 2018Recall initiated by company
17 Sep 2018Classified by FDA+13 days
26 Sep 2018Published in enforcement report+9 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Presence of Foreign Tablets/Capsules: Glimepiride tablet was found in a bottle of Tinzadine Hcl Tablets .

Product as listed by the FDA

Tizanidine HCl Tablets, USP 2mg, 150-count bottles, Rx Only, Mfd. By: Dr. Reddy's Laboratories Limited Srilakulam - 532 409 INDIA, NDC 55111-179-15, UPC 35511179153

Where it was distributed

Nationwide within the United States

Nationwide

Questions about this recall

Is Tizanidine HCl Tablets, USP 2mg recalled?

Yes. Dr. Reddy's Laboratories recalled Tizanidine HCl Tablets, USP 2mg on 4 Sep 2018. The recall is Class II and its status is Terminated. Recall number D-1191-2018.

Why was it recalled?

Presence of Foreign Tablets/Capsules: Glimepiride tablet was found in a bottle of Tinzadine Hcl Tablets .

Which lots are affected?

Lot #: T800304, Exp. 03/2021

Where was it sold?

Nationwide within the United States

What should I do if I have it?

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 21 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Dr. Reddy's Laboratories

All 165

Other Tizanidine recalls

All 11